We are live on
!
Find out more
Sana Biotechnology
SANA
SANA
154 hedge funds and large institutions have $1.46B invested in Sana Biotechnology in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 46 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
186% more capital invested
Capital invested by funds: $511M → $1.46B (+$952M)
153% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 15
61% more call options, than puts
Call options by funds: $3.96M | Put options by funds: $2.47M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
17% more funds holding
Funds holding: 132 → 154 (+22)
15% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 40
2.83% more ownership
Funds ownership: 63.54% → 66.38% (+2.8%)
Holders
154
Holders Change
+22
Holders Change %
+16.67%
% of All Funds
2.22%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
38
Increased
46
Reduced
40
Closed
15
Calls
$3.96M
Puts
$2.47M
Net Calls
+$1.5M
Net Calls Change
+$3.14M
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$16.4M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$9.05M |
| 3 |
SCM
Suvretta Capital Management
New York
|
-$6.55M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$6.1M |
| 5 |
Barclays
London,
United Kingdom
|
-$1.76M |
